ATTAC-II is a clinical trial led by Duane Mitchell, MD, PhD. He is the co-director of the Preston A. Wells Jr. Center for Brain Tumor Therapy at the University of Florida. This study focuses on adults who are battling brain and spinal cancer. Dr. Mitchell and his team are working to harness the body’s own immune system cells to fight off the invading tumor.